Selective 5-Hydroxytryptamine Type 3 Receptor Antagonism With Ondansetron as Treatment for Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Study
1992 ◽
Vol 67
(8)
◽
pp. 732-738
◽
Keyword(s):
2012 ◽
Vol 35
(3)
◽
pp. 360-367
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2008 ◽
Vol 6
(5)
◽
pp. 545-555
◽
2009 ◽
Vol 24
(5)
◽
pp. 423-428
◽
2017 ◽
Vol 30
(1)
◽
pp. e13223
◽
Keyword(s):